What's new

Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 58, Status: Authorised

Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 58, Status: Authorised

Mar 17, 2025 - 16:46
 0
Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 58, Status: Authorised
Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 58, Status: Authorised
Read More

Tags:

Previous Article

PepsiCo to Acquire Better-for-you Soda Brand Poppi for $1.95 Billion

Next Article

NIH-sponsored trial of Lassa vaccine opens

Related Posts

Product Management Service (PMS) questions and aswers clinic - May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 May 2025, 15:00 (CEST) to 19 May 2025, 16:00 (CEST)

Product Management Service (PMS) questions and aswers c...

Mar 7, 2025  0

EMEA-003174-PIP01-21-M01

EMEA-003174-PIP01-21-M01

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Memantine Mylan, memantine, Date of authorisation: 21/04/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0